GleamWall
中文EN

ACAT NP Life Sciences Health Industry Group Inc.

Services-Educational Services · OTC · SEC CIK 1781726 · Fiscal year ends 12/31

Financial factors as of 2023-12-31 (2023Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY202.8%
TTM EPS YoY—
Revenue 3-yr CAGR112.8%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-0.5%
Net margin13.4%
FCF margin—
EBITDA margin—

Returns

ROE108.6%
ROA19.0%
ROIC (approx.)—
Asset turnover1.41x

Leverage & solvency

Liabilities / assets78.7%
Debt / equity0.00x
Current ratio—
Interest coverage—

Cash quality & payout

Operating cash flow / net income-3.80x
Accruals ratio90.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20232023-12-31FY20222022-12-31
Income statement
Revenue$144,599$102,002
SG&A expense$165,311$120,857
Operating income-$690-$18,855
Interest expense$645$1
Pretax income-$1,335-$18,856
Income tax$1,600—
Net income-$2,935-$18,856
EPS (basic)0.000.00
EPS (diluted)0.000.00
Weighted avg. shares (diluted)42.96M42.96M
Banking
Net interest income—-$1
Balance sheet
Cash & equivalents$70,614$121,859
Total assets$76,864$127,784
Current liabilities$38,121$108,468
Total liabilities$60,483$108,468
Shareholders' equity$16,381$19,316
Shares outstanding42.96M42.96M
Cash flow statement
Operating cash flow-$73,607$93,873
Financing cash flow$22,362—

Free plan shows the latest 2 periods; Pro shows all 5 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.